Processa Pharmaceuticals, Inc. Net Cash Provided by (Used in) Discontinued Operations
Processa Pharmaceuticals, Inc. (PCSA) reported Net Cash Provided by (Used in) Discontinued Operations of -$12.35 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-09-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInDiscontinuedOperations · last filed 2017-09-25
- Processa Pharmaceuticals, Inc. net cash provided by (used in) discontinued operations for the quarter ending 2016-12-31 was -$3.54K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) discontinued operations for the quarter ending 2016-09-30 was -$42.00.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) discontinued operations for the quarter ending 2016-06-30 was -$2.30K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) discontinued operations for the quarter ending 2016-03-31 was -$6.47K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) discontinued operations for fiscal 2016 was -$12.35K.
- Processa Pharmaceuticals, Inc. net cash provided by (used in) discontinued operations for fiscal 2015 was -$231.36K.
| Period end | Net Cash Provided by (Used in) Discontinued Operations 3 month | Net Cash Provided by (Used in) Discontinued Operations 6 month | Net Cash Provided by (Used in) Discontinued Operations 9 month | Net Cash Provided by (Used in) Discontinued Operations 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$3.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$3.58K derived: sum of 2 quarters · filed 2017-09-25 | -$5.88K derived: sum of 3 quarters · filed 2017-09-25 | -$12.35K 10-K · filed 2017-09-25 |
| 2016-09-30 | -$42.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$2.34K derived: sum of 2 quarters · filed 2017-09-08 | -$8.81K 10-Q · filed 2017-09-08 | |
| 2016-06-30 | -$2.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$8.77K 10-Q · filed 2017-08-30 | ||
| 2016-03-31 | -$6.47K 10-Q · filed 2017-08-07 | |||
| 2015-12-31 | -$231.36K 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |